Dx Deals: Quest Closes PathAI Partial Acquisition and Strategic Alliance
Deal is expected to give the lab giant a big boost in deploying artificial intelligence in the pathology space.
Keeps You Up-to-Date on Lab Business and Competitive Strategy, Market Trends and Opportunities, and M&A and Investment Activity in Today’s Diagnostic Lab Industry
Deal is expected to give the lab giant a big boost in deploying artificial intelligence in the pathology space.
From - Laboratory Industry Report
A study reveals that for today's hourly workforce, missing a single shift comes at a steep cost…
From - Laboratory Industry Report
Here's a summary of the key product launches announced from late July through the third week of…
From - Laboratory Industry Report
Lab business is getting tougher. While PAMA cuts are hurting Medicare revenues, pressure from private payors may…
From - Laboratory Industry Report
The business of enforcing federal health care fraud laws isn't as robust as it used to be. While revenues have…
From - Laboratory Industry Report
Several companies market an array of preventive tests directly to consumers. Are these companies and tests legit? What does…
By Sean McSweeney bio
Does your orthopedic billing company charge a percentage of collections for their coding and billing…
From - Laboratory Industry Report
The strategic deal making pot continues to boil, despite the relative inactivity of the established market leaders like Quest, LabCorp and Abbott. Here's a look at…